Label: SENNA- sennosides tablet

  • NDC Code(s): 62011-0387-1
  • Packager: STRATEGIC SOURCING SERVICES LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated October 16, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Sennosides 8.6 mg

  • Purpose

    Laxative

  • Uses

    • this product generally produces a bowel movement in 6 to 12 hours
    • relieves occasional constipation (irregularity)
  • Warnings

    Do not use for more than one week unless directed by a doctor.

    Ask a doctor before use if you

    • have abdominal pain, nausea or vomiting
    • have noticed a sudden change in bowel habits that lasts over two weeks

    Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use if a laxative. These may indicate a serious condition.

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    • do not exceed 8 tablets in 24 hours
    AgeStarting DoseMaximum Dose
    adults and children 12 years of age and older2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor4 tablets in the morning and 4 tablets at bedtime
    children under 12 yearsask a doctor



  • Other information

    • each tablet contains: calcium 40 mg
    • store at room temperature 15-30C (59-86F)
  • Inactive ingredients

    cellulose, croscarmellose sodium, dicalcium phosphate, hypromellose*, magnesium silicate*, magnesium stearate, mineral oil*, PEG*, silica*, wax*.
    *May contain these ingredients.

  • package label

    451

  • INGREDIENTS AND APPEARANCE
    SENNA 
    sennosides tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:62011-0387
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    CARNAUBA WAX (UNII: R12CBM0EIZ)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: L11K75P92J)  
    MAGNESIUM SILICATE (UNII: 9B9691B2N9)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MINERAL OIL (UNII: T5L8T28FGP)  
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    Product Characteristics
    ColorbrownScoreno score
    ShapeROUNDSize8mm
    FlavorImprint Code AZ217
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:62011-0387-11 in 1 CARTON10/01/2018
    1100 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00710/01/201804/30/2024
    Labeler - STRATEGIC SOURCING SERVICES LLC (116956644)
    Registrant - Geri-Care Pharmaceutical Corp (611196254)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!